[Background] Thrombosis is a characteristic complication in Coronavirus disease 2019
(COVID-19). Since coagulopathy has been observed over the entire clinical course …

A questionnaire on COVID-19-related thrombosis in patients hospitalized before Aug 31,
2020, was sent to 399 hospitals throughout Japan. Responses were received from 111 …

Background Patients with coronavirus disease 2019 (Covid-19) may experience venous
thrombosis while data regarding arterial thrombosis are sparse. Methods Prospective …

Background Arterial and venous thrombosis are reported to be common in critically ill
COVID-19 patients. Method and results This is a national multicenter retrospective …

COVID-19 is associated with a variety of clinical complications including coagulopathy,
which frequently results in venous thromboembolism (VTE). Retrospective analyses …

Background Coagulation abnormalities in COVID-19 patients accompanied with poor
prognosis. This study aimed to determine the prevalence and risk factors of thrombotic …

Objective We have summarized the incidence, anticoagulation panels, laboratory
characteristics, and mortality of venous thromboembolism (VTE) in hospitalized patients with …

Background Several observational studies have reported the rate of venous and arterial
thrombotic events in patients infected with COVID-19, with conflicting results. The aim of this …

Objective In the present study, we sought to better characterize the patients with coronavirus
disease 2019 (COVID-19) most at risk of severe, outpatient thrombosis by defining the …

Abstract Background Coronavirus disease 2019 (COVID‐19) can lead to systemic
coagulation activation and thrombotic complications. Objectives To investigate the incidence …